Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

21%

6 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

17 recruiting

Enrollment Performance

Analytics

Phase 2

6(31.6%)

Phase 3

6(31.6%)

N/A

5(26.3%)

Phase 1

2(10.5%)

19Total

Phase 2(6)

Phase 3(6)

N/A(5)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials

NCT07590024Phase 3Recruiting

RAIRI-Guided Adjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Role: collaborator

NCT07002346Phase 3Recruiting

INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Role: collaborator

NCT06783647Phase 2Recruiting

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Role: collaborator

NCT07493044Phase 1Recruiting

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Role: collaborator

NCT07298616Not ApplicableCompleted

Hydrodissection Tunneling Technique on Recurrent Laryngeal Nerve Protection During Thyroidectomy

Role: collaborator

NCT05831891Phase 2Active Not Recruiting

Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma

Role: collaborator

NCT04276532Not ApplicableActive Not Recruiting

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Role: collaborator

NCT07311772Phase 3Recruiting

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Role: collaborator

NCT07013461Recruiting

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Role: collaborator

NCT07562763Completed

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Role: collaborator

NCT07539753Phase 2Not Yet Recruiting

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Role: collaborator

NCT06767007Phase 2Recruiting

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Role: collaborator

NCT07539792Phase 2Recruiting

Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study

Role: collaborator

NCT07428642Completed

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Role: collaborator

NCT07452848Recruiting

Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy

Role: collaborator

NCT02767661Phase 3Completed

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer

Role: collaborator

NCT06839157Active Not Recruiting

Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer

Role: collaborator

NCT06099912Recruiting

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07374614Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Role: collaborator